JS Capital Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
JS Capital Management's IMMU Position: Q4 2020 in Review
JS Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 13,300 shares — an estimated $1.13M sold.
JS Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $1.13M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- JS Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- JS Capital Management sold 13,300 Immunomedics Inc shares in Q4 2020, an estimated $1.13M.
- JS Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
- JS Capital Management's Immunomedics Inc position peaked at $1.13M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on JS Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.